Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Benson, Chellakkan Selvanesan"'
Autor:
Wei Du, Christian Adkisson, Xianjun Ye, Camille L. Duran, Benson Chellakkan Selvanesan, Claudia Gravekamp, Maja H. Oktay, John C. McAuliffe, John S. Condeelis, Nicole C. Panarelli, Robert J. Norgard, Yogev Sela, Ben Z. Stanger, David Entenberg
Publikováno v:
Open Biology, Vol 12, Iss 6 (2022)
Pancreatitis and pancreatic ductal adenocarcinoma (PDAC) are grave illnesses with high levels of morbidity and mortality. Intravital imaging (IVI) is a powerful technique for visualizing physiological processes in both health and disease. However, th
Externí odkaz:
https://doaj.org/article/5cd0bdd3d6f646ecb9b1fad67b28a260
Autor:
Ilse Rooman, Claudia Gravekamp, Lydie Meheus, Amanda Beck, Benson Chellakkan Selvanesan, Kiran Meena, Olaya Lara
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Treatments for pancreatic ductal adenocarcinoma are poorly effective, at least partly due to the tumor’s immune-suppressive stromal compartment. New evidence of positive effects on immune responses in the tumor microenvironment (TME), co
Externí odkaz:
https://doaj.org/article/a874e3fb0655429482879cb32148b701
Autor:
Benson Chellakkan Selvanesan, Alvaro de Mingo Pulido, Sheelu Varghese, Deepak Rohila, Daniel Hupalo, Yuriy Gusev, Sara Contente, Matthew D. Wilkerson, Clifton L. Dalgard, Geeta Upadhyay
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1468
Volume 15
Issue 5
Pages: 1468
NSC243928 induces cell death in triple-negative breast cancer cells in a LY6K-dependent manner. NSC243928 has been reported as an anti-cancer agent in the NCI small molecule library. The molecular mechanism of NSC243928 as an anti-cancer agent in the
Autor:
Arthee Jahangir, Dinesh Chandra, Wilber Quispe-Tintaya, Manisha Singh, Benson Chellakkan Selvanesan, Claudia Gravekamp
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
Cancer immunotherapy is one of the most promising and benign therapies against metastatic cancer. However, most cancer patients are old and elderly react less efficient to cancer vaccines than young adults, due to T cell unresponsiveness. Here we pre
Externí odkaz:
https://doaj.org/article/c28cda46018545a59ff93a228a74fb44
Autor:
Benson Chellakkan Selvanesan, Sheelu Varghese, Justyna Andrys-Olek, Ricardo Hernandez Arriaza, Rahul Prakash, Purushottam Babu Tiwari, Daniel Hupalo, Yuriy Gusev, Megha Nitin Patel, Sara Contente, Miloslav Sanda, Aykut Uren, Matthew D. Wilkerson, Clifton Lee Dalgard, Linda S. Shimizu, Maksymilian Chruszcz, Tomasz Borowski, Geeta Upadhyay
Publikováno v:
Cancer Letters. 558:216094
Autor:
Elumalai, Perumal, Gunadharini, Dharmalingam Nandagopal, Senthilkumar, Kalimuthu, Banudevi, Sivanantham, Arunkumar, Ramachandran, Benson, Chellakkan Selvanesan, Sharmila, Govindaraj, Arunakaran, Jagadeesan
Publikováno v:
In Biomedicine & Preventive Nutrition January-March 2012 2(1):59-68
Autor:
Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe-Tintaya, Arthee Jahangir, Ankur Patel, Kiran Meena, Rodrigo Alberto Alves Da Silva, Madeline Friedman, Lisa Gabor, Olivia Khouri, Steven K. Libutti, Ziqiang Yuan, Jenny Li, Sarah Siddiqui, Amanda Beck, Lydia Tesfa, Wade Koba, Jennifer Chuy, John C. McAuliffe, Rojin Jafari, David Entenberg, Yarong Wang, John Condeelis, Vera DesMarais, Vinod Balachandran, Xusheng Zhang, Ken Lin, Claudia Gravekamp
Publikováno v:
Sci Transl Med
Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease. Tumors are poorly immunogenic and immunosuppressive, preventing T cell activation in the tumor microenvironment. Here, we present a microbial-based immunotherapeutic treatment fo
Autor:
null Wei Du, null Christian Adkisson, null Xianjun Ye, null Camille L. Duran, null Benson Chellakkan Selvanesan, null Claudia Gravekamp, null Maja H. Oktay, null John C. McAuliffe, null John S. Condeelis, null Nicole C. Panarelli, null Robert J. Norgard, null Yogev Sela, null Ben Z. Stanger, null David Entenberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ede51c82db94e464451ab4aedc1c15
https://doi.org/10.1098/rsob.210273/v2/response1
https://doi.org/10.1098/rsob.210273/v2/response1
Autor:
Claudia Gravekamp, Benson Chellakkan Selvanesan, Amanda P. Beck, Olaya Lara, Kiran Meena, Lydie Meheus, Ilse Rooman
Publikováno v:
Journal for Immunotherapy of Cancer
BackgroundTreatments for pancreatic ductal adenocarcinoma are poorly effective, at least partly due to the tumor’s immune-suppressive stromal compartment. New evidence of positive effects on immune responses in the tumor microenvironment (TME), com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71963dcab46c83655c6713ebcea7c396
https://doi.org/10.1101/2020.06.02.129809
https://doi.org/10.1101/2020.06.02.129809
Autor:
Gunilla Jönsson, Benson Chellakkan Selvanesan, Kishan Bellamkonda, Sayeh Savari, Shakti Ranjan Satapathy, Desiree Douglas, Minghui Liu, Anita Sjölander, Naveenkumar Chandrashekar
Publikováno v:
Cancer Letters. 437:13-24
Inflammation is implicated in the etiology of sporadic colon cancer (CC), which is one of the leading causes of cancer-related deaths worldwide. Here, we report that inhibition of the inflammatory receptor CysLT1 through its antagonist, montelukast,